What do patients think about carrying Overdose-Reversal spray?
NCT ID NCT04129138
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study surveys 182 high-risk patients and their caregivers to understand their attitudes and beliefs about being prescribed intranasal naloxone spray, a medication that can reverse an opioid overdose. The goal is to identify barriers to prescribing and to improve education for patients and caregivers. No treatment is given; it is purely a knowledge-gathering study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAREGIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.